Mr. Sina Pirooz reports

GENIX PHARMACEUTICALS CORPORATION ANNOUNCES ADOPTION OF SEMI-ANNUAL REPORTING

Genix Pharmaceuticals Corp. is adopting semi-annual financial reporting. This news release is being filed pursuant to Coordinated Blanket Order 51-933, Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers.

CBO 51-933 allows eligible venture issuers to voluntarily transition from a quarterly to a semi-annual financial reporting framework. Genix's fiscal year ends on Oct. 31. Under the provisions of CBO 51-933, Genix will be exempt from the requirement to file its interim financial statements and associated management's discussion and analysis (MD&A) for the nine-month interim period, as it meets the eligibility criteria under CBO 51-933, including being a venture issuer with annual revenues of less than $10-million and maintaining a clean 12-month continuous disclosure record. The company has already filed its interim financial statements and MD&A for the three-month period ended Jan. 31, 2026. Accordingly, Genix will issue its six-month interim financial statements and MD&A for the period ending April 30, 2026, but will not file its interim financial statements and associated MD&A for the nine-month period ending July 31, 2026, as permitted under CBO 51-933.

Genix will continue to file audited annual financial statements (due within 120 days of Oct. 31, 2026) and six-month interim financial reports (due within 60 days of April 30, 2026). Genix remains committed to timely disclosure and will continue to report all material changes and significant developments in accordance with National Instrument 51-102, Continuous Disclosure Obligations.

About Genix Pharmaceuticals Corp.

Genix Pharmaceuticals is a Canadian technology company focused on the development of artificial intelligence-based sensing and spatial intelligence solutions. The company's proprietary technology utilizes Wi-Fi and radio signals to monitor and analyze environments without the need for specialized hardware, with applications across health care, security and smart infrastructure sectors.

We seek Safe Harbor.